High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.


Oner G., Önder S., Karatay H., Tükenmez M., Muslumanoglu M., Igci A., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.36, 2018 (SCI-Expanded) identifier